NMDP BioTherapies
NMDP BioTherapies
  • Видео 33
  • Просмотров 11 079
When does outsourcing autologous CC qualification and the cell therapy supply chain make sense?
The first autologous CAR-T therapy was approved in 2017, and the industry has since gained substantial operating experience, treating tens of thousands of patients globally. Some drug sponsors have developed in-house teams to manage, improve, and maintain the infrastructure needed for these complex therapies, while others have opted to outsource these responsibilities. The supply chain for autologous CAR-T therapies has been a focus of improvement since the early trials, especially the transport of cells. Significant investment have aimed to make the supply chain more predictable and reliable.
While outsourcing the supply chain to a single logistics supplier is now more feasible, active ma...
Просмотров: 18

Видео

Understanding and leveraging cord blood bank capabilities and practices in cell therapy development
Просмотров 2316 часов назад
The cord blood banking industry has been around for over 30 years, focusing on acquiring units for use in hematopoietic stem cell transplant. Recent research indicates that cord blood can be a valuable source of naïve cells for cell therapy manufacturing. Cord blood banks are evolving their processes to accommodate the use of cord blood units for these new and evolving purposes. This helps deve...
Optimizing access to high-quality, compliant leukopaks for allogeneic therapy development
Просмотров 496 месяцев назад
Cellular starting material is the most critical component in the allogeneic cell therapy manufacturing process. Ensuring material access while maintaining quality, consistency, and regulatory compliance are necessary throughout every stage of clinical development through commercialization. As the development of allogeneic therapies continues to expand, having an industry-wide focus on standardi...
Bioinformatics Consulting for Cell and Gene Therapy
Просмотров 607 месяцев назад
Do you need to build a cell bank to maximize target population coverage? Are you unsure of the odds of finding donors that will match your cell therapy criteria? Do you need to know how your allogeneic donor choices for source material will impact your therapy? Or if you can use your human leukocyte antigen (HLA) data that has significant gaps and ambiguities? Our Bioinformatics Consulting team...
Cord Blood Units for Allogeneic Cell Therapy Source Material
Просмотров 527 месяцев назад
Our Cord Blood Unit Sourcing service offers a central point to access fully characterized CBUs through our contracted NMDP BioTherapies℠ Cord Blood Bank Alliance. We qualify and contract with high-performing cord blood banks that are motivated to supply their CBUs for emerging cell therapy development and commercialization. NMDP BioTherapies understands the varying capabilities of each bank, so...
CIBMTR® CRO Services for Cell and Gene Therapy
Просмотров 1637 месяцев назад
Our CIBMTR CRO Services set your cell therapy clinical trial up for success and help you mitigate risk. Because the CIBMTR is a research affiliation between NMDP℠ and the Medical College of Wisconsin, you leverage a powerhouse of support and the established infrastructure and stability that goes along with it. We are both a sponsor running our own clinical trials and a CRO running trials for ot...
Proven Solutions for Developing Cell and Gene Therapies
Просмотров 1207 месяцев назад
NMDP BioTherapies is the only cell and gene therapy solutions provider with customizable services to support the end-to-end cell therapy supply chain. Backed by the industry-leading experience of NMDP℠ and a research partnership with the CIBMTR® (Center for International Blood and Marrow Transplant Research®), the organization designs solutions that advance the development of cell and gene ther...
GMP Allogeneic Starting Material for Cell and Gene Therapy
Просмотров 1587 месяцев назад
Accelerate your allogeneic cell therapy program development with NMDP BioTherapies allogeneic donor cells. We help you obtain high-quality cellular source material for therapy development and commercialization through the most diverse registry in the world, the NMDP Registry℠. Our standard leukopak collections include a drug master file (DMF) on file and comply with applicable FDA regulations. ...
Novel Allogeneic Cellular Therapies: Predictions for the Future-ONE Forum session
Просмотров 372 года назад
Over the last several years, there has been increasing global investment in the development of novel allogeneic cell and gene therapies. A recent study published by Nature Reviews Drug Discovery estimates that in 2021 over 400 allogeneic cellular therapies are under development across the globe, many of which are focused on hematological malignancies that have traditionally been treated with BM...
Making the Impossible Possible | Be The Match BioTherapies
Просмотров 2712 года назад
Navigating a time-sensitive cell therapy supply chain during the COVID-19 pandemic.
Cell Sourcing Solutions
Просмотров 463 года назад
You need donor starting material for your allogeneic cell therapy. But not all cell providers are alike. Discover how we deliver high-quality cell therapy source material. Learn more: bethematchbiotherapies.com/solutions/cell-sourcing/
Discover how we deliver high-quality cell therapy source material
Просмотров 3463 года назад
You need donor starting material for your allogeneic cell therapy. But not all cell providers are alike. Learn what sets us apart. More information: bethematchbiotherapies.com/solutions/cell-sourcing/
Develop a reliable Collection Network for high-quality collections
Просмотров 1253 года назад
You need a streamlined process for developing and maintaining a high-quality Collection Network for you cell therapy. Learn how we can help. More information: bethematchbiotherapies.com/solutions/collection-network-development-and-management
HLA’s Future Impact on Allogeneic Cell Therapy Development
Просмотров 2553 года назад
Martin Maiers, MS, Vice President of Innovation at NMDP/Be The Match, discusses HLA’s impact on future allogeneic cell therapy development, from cell bank creation to maximizing population coverage. Read our full interview on the Be The Match BioTherapies Cell Lines blog: bethematchbiotherapies.com/cell-lines-blog/hla-impact-allogeneic-cell-therapy-development/
Personalized Cell Therapy Supply Chain Management | Be The Match BioTherapies
Просмотров 443 года назад
What does it take to manage a complex human-based supply chain and deliver time-sensitive cell therapies on time? Orchestrating cell therapy logistics is complex and susceptible to variability at each point of the supply chain. Discover how we help your company navigate the variability of human-based supply chains and manage your risk. More information: bethematchbiotherapies.com/solutions/cell...
Be Confident in On-Time Delivery of Your Cell Therapy | Be The Match BioTherapies
Просмотров 6 тыс.3 года назад
Be Confident in On-Time Delivery of Your Cell Therapy | Be The Match BioTherapies
2020 Year In Review | Be The Match BioTherapies
Просмотров 663 года назад
2020 Year In Review | Be The Match BioTherapies
Delivering Life-Saving Cellular Therapies During a Pandemic
Просмотров 643 года назад
Delivering Life-Saving Cellular Therapies During a Pandemic
Overcoming Logistics and Supply Chain Challenges During COVID-19
Просмотров 804 года назад
Overcoming Logistics and Supply Chain Challenges During COVID-19
Virtual Onboarding & Training for Apheresis Centers During COVID-19
Просмотров 804 года назад
Virtual Onboarding & Training for Apheresis Centers During COVID-19
Be The Match CEO Amy Ronneberg on Working From Home
Просмотров 1164 года назад
Be The Match CEO Amy Ronneberg on Working From Home
Delivering Life: A Volunteer Story
Просмотров 4694 года назад
Delivering Life: A Volunteer Story
Our Response to COVID-19
Просмотров 514 года назад
Our Response to COVID-19
Challenges Facing Collection Centers and Cell and Gene Therapy Companies | Be The Match BioTherapies
Просмотров 744 года назад
Challenges Facing Collection Centers and Cell and Gene Therapy Companies | Be The Match BioTherapies
Exciting Growth in the Cell Therapy Field | Be The Match BioTherapies
Просмотров 474 года назад
Exciting Growth in the Cell Therapy Field | Be The Match BioTherapies
The Impact of New Cell Therapies for Patients | Be The Match BioTherapies
Просмотров 464 года назад
The Impact of New Cell Therapies for Patients | Be The Match BioTherapies
Supporting Collection Centers and Cell and Gene Therapy Companies | Be The Match BioTherapies
Просмотров 274 года назад
Supporting Collection Centers and Cell and Gene Therapy Companies | Be The Match BioTherapies
Cell and Gene Therapy Companies Overcome Challenges | Be The Match BioTherapies
Просмотров 344 года назад
Cell and Gene Therapy Companies Overcome Challenges | Be The Match BioTherapies
Proven Solutions for Developing Cell and Gene Therapies | Be The Match BioTherapies
Просмотров 9784 года назад
Proven Solutions for Developing Cell and Gene Therapies | Be The Match BioTherapies
Cell and Gene Therapy Supply Chain Solutions | Be The Match BioTherapies
Просмотров 5474 года назад
Cell and Gene Therapy Supply Chain Solutions | Be The Match BioTherapies